NetworkNewsBreaks – Flora Growth Corp. (NASDAQ:
Post# of 278
(Total Views: 180)
Posted On: 10/25/2021 5:29:12 PM
NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Opens Pathway to Dry Flower Export Through Receipt of GACP Certification
Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its receipt of the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). According to the update, paired with the recent Colombian law change, Flora can now export its high-quality dry flower to international GMP active pharmaceutical ingredient (“API”) producers or to markets where flower can be imported. “In advance of this milestone, our team has signed several LOIs for the sale and distribution of dry flower and derivative products to several international jurisdictions, including the EU, Australia and Latin America. We are now in the position to unlock the significant potential from Cosechemos as we continue building our global distribution network,” said Jason Warnock, chief revenue officer of Flora Growth. “Our team believes this certification demonstrates our ability to offer high-quality output, while also serving as an important precursor to GMP certification so that we can produce pharmaceutical-grade cannabis products and cannabinoid-based active pharmaceutical ingredients.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its receipt of the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). According to the update, paired with the recent Colombian law change, Flora can now export its high-quality dry flower to international GMP active pharmaceutical ingredient (“API”) producers or to markets where flower can be imported. “In advance of this milestone, our team has signed several LOIs for the sale and distribution of dry flower and derivative products to several international jurisdictions, including the EU, Australia and Latin America. We are now in the position to unlock the significant potential from Cosechemos as we continue building our global distribution network,” said Jason Warnock, chief revenue officer of Flora Growth. “Our team believes this certification demonstrates our ability to offer high-quality output, while also serving as an important precursor to GMP certification so that we can produce pharmaceutical-grade cannabis products and cannabinoid-based active pharmaceutical ingredients.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)